Encompass Health Corp
EHC104.664USD
-1.476-1.39%
Market hours （ET）Quotes delayed by 15 min
10.53BMarket Cap
19.49P/E TTM
More Details of Encompass Health Corp Company
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
Encompass Health Corp Info
Ticker SymbolEHC
Company nameEncompass Health Corp
IPO dateSep 24, 1986
CEOTarr (Mark J)
Number of employees23564
Security typeOrdinary Share
Fiscal year-endSep 24
Address9001 Liberty Pkwy
CityBIRMINGHAM
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code35242-7509
Phone12059677116
Websitehttps://www.encompasshealth.com/
Ticker SymbolEHC
IPO dateSep 24, 1986
CEOTarr (Mark J)
Company Executives of Encompass Health Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Mark J. Tarr
Mr. Mark J. Tarr
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
527.07K
--
Mr. Douglas E. (Doug) Coltharp
Mr. Douglas E. (Doug) Coltharp
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
251.19K
--
Mr. Edmund M. (Ed) Fay
Mr. Edmund M. (Ed) Fay
Senior Vice President, Treasurer
Senior Vice President, Treasurer
95.27K
-3.71%
Ms. Leslye G Katz
Ms. Leslye G Katz
Independent Director
Independent Director
47.75K
+0.15%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Independent Director
Independent Director
21.22K
+0.16%
Mr. Patrick W. (Pat) Tuer
Mr. Patrick W. (Pat) Tuer
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
18.85K
-5.13%
Mr. Gregory D. (Greg) Carmichael
Mr. Gregory D. (Greg) Carmichael
Independent Director
Independent Director
18.63K
+0.12%
Mr. Terrance Williams
Mr. Terrance Williams
Independent Director
Independent Director
15.14K
+0.15%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Independent Director
Independent Director
15.09K
+2.06%
Dr. Elissa Joy Charbonneau
Dr. Elissa Joy Charbonneau
Chief Medical Officer
Chief Medical Officer
11.96K
-26.35%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Mark J. Tarr
Mr. Mark J. Tarr
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
527.07K
--
Mr. Douglas E. (Doug) Coltharp
Mr. Douglas E. (Doug) Coltharp
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
251.19K
--
Mr. Edmund M. (Ed) Fay
Mr. Edmund M. (Ed) Fay
Senior Vice President, Treasurer
Senior Vice President, Treasurer
95.27K
-3.71%
Ms. Leslye G Katz
Ms. Leslye G Katz
Independent Director
Independent Director
47.75K
+0.15%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Independent Director
Independent Director
21.22K
+0.16%
Mr. Patrick W. (Pat) Tuer
Mr. Patrick W. (Pat) Tuer
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
18.85K
-5.13%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Medicare
939.70M
64.46%
Medicare Advantage
246.00M
16.88%
Managed Care
163.00M
11.18%
Medicaid
45.20M
3.10%
Other Income Source
41.30M
2.83%
Other
22.50M
1.54%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Medicare
939.70M
64.46%
Medicare Advantage
246.00M
16.88%
Managed Care
163.00M
11.18%
Medicaid
45.20M
3.10%
Other Income Source
41.30M
2.83%
Other
22.50M
1.54%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.15%
BlackRock Institutional Trust Company, N.A.
8.43%
Invesco Advisers, Inc.
4.45%
T. Rowe Price Associates, Inc.
3.74%
State Street Investment Management (US)
3.06%
Other
70.16%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.15%
BlackRock Institutional Trust Company, N.A.
8.43%
Invesco Advisers, Inc.
4.45%
T. Rowe Price Associates, Inc.
3.74%
State Street Investment Management (US)
3.06%
Other
70.16%
Shareholder Types
Shareholders
Proportion
Investment Advisor
49.19%
Investment Advisor/Hedge Fund
34.64%
Hedge Fund
6.41%
Bank and Trust
2.15%
Pension Fund
2.06%
Research Firm
1.80%
Individual Investor
1.50%
Sovereign Wealth Fund
1.24%
Insurance Company
0.13%
Other
0.88%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
1064
98.33M
97.73%
-1.53M
2025Q3
1072
97.93M
99.39%
+709.65K
2025Q2
1033
97.25M
101.81%
-1.92M
2025Q1
979
99.67M
102.60%
-3.66M
2024Q4
945
99.00M
102.85%
-881.71K
2024Q3
884
99.36M
106.17%
-310.63K
2024Q2
889
99.51M
109.15%
-995.73K
2024Q1
858
100.71M
112.68%
-12.13M
2023Q4
852
101.16M
110.27%
+2.80M
2023Q3
865
97.95M
111.77%
+322.90K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
10.22M
10.15%
-140.47K
-1.36%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
8.48M
8.43%
-4.83K
-0.06%
Sep 30, 2025
Invesco Advisers, Inc.
4.48M
4.45%
-276.20K
-5.81%
Sep 30, 2025
T. Rowe Price Associates, Inc.
3.77M
3.74%
+2.44M
+184.81%
Sep 30, 2025
State Street Investment Management (US)
3.08M
3.06%
-24.31K
-0.78%
Sep 30, 2025
Wellington Management Company, LLP
2.78M
2.76%
-744.16K
-21.11%
Sep 30, 2025
AllianceBernstein L.P.
2.52M
2.5%
+476.56K
+23.37%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
2.14M
2.13%
-34.67K
-1.59%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
2.06M
2.05%
+238.21K
+13.06%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.81M
1.8%
+34.70K
+1.96%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
PGIM Jennison Focused Mid-Cap ETF
3.17%
Inspire Growth ETF
2.88%
Opus Small Cap Value ETF
2.23%
State Street SPDR S&P Health Care Services ETF
1.86%
iShares U.S. Healthcare Providers ETF
1.8%
ALPS O'Shares US Small-Cap Quality Dividend ETF
1.74%
Bahl & Gaynor Dividend ETF
1.5%
Invesco Dorsey Wright Healthcare Momentum ETF
1.18%
JPMorgan Active Small Cap Value ETF
1.09%
iShares MSCI USA Small-Cap Min Vol Factor ETF
1.07%
View more
PGIM Jennison Focused Mid-Cap ETF
Proportion3.17%
Inspire Growth ETF
Proportion2.88%
Opus Small Cap Value ETF
Proportion2.23%
State Street SPDR S&P Health Care Services ETF
Proportion1.86%
iShares U.S. Healthcare Providers ETF
Proportion1.8%
ALPS O'Shares US Small-Cap Quality Dividend ETF
Proportion1.74%
Bahl & Gaynor Dividend ETF
Proportion1.5%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion1.18%
JPMorgan Active Small Cap Value ETF
Proportion1.09%
iShares MSCI USA Small-Cap Min Vol Factor ETF
Proportion1.07%
Dividend
A total of
334.60M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Oct 23, 2025
EHC.NB Final Cash Dividend of gross USD 0.19 paid on Jan 15, 2026 going ex on Jan 02, 2026
Jan 02, 2026
Jan 15, 2026
Jan 02, 2026
Jul 24, 2025
EHC.NB Interim Cash Dividend of gross USD 0.19 paid on Oct 15, 2025 going ex on Oct 01, 2025
Oct 01, 2025
Oct 15, 2025
Oct 01, 2025
May 01, 2025
EHC.NB Interim Cash Dividend of gross USD 0.17 paid on Jul 15, 2025 going ex on Jul 01, 2025
Jul 01, 2025
Jul 15, 2025
Jul 01, 2025
Feb 20, 2025
EHC.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 15, 2025 going ex on Apr 01, 2025
Apr 01, 2025
Apr 15, 2025
Apr 01, 2025
Oct 17, 2024
EHC.NB Final Cash Dividend of gross USD 0.17 paid on Jan 15, 2025 going ex on Jan 02, 2025
Jan 02, 2025
Jan 15, 2025
Jan 02, 2025
Jul 24, 2024
EHC.NB Interim Cash Dividend of gross USD 0.17 paid on Oct 15, 2024 going ex on Oct 01, 2024
Oct 01, 2024
Oct 15, 2024
Oct 01, 2024
May 02, 2024
EHC.NB Interim Cash Dividend of gross USD 0.15 paid on Jul 15, 2024 going ex on Jul 01, 2024
Jul 01, 2024
Jul 15, 2024
Jul 01, 2024
Feb 28, 2024
EHC.NB Interim Cash Dividend of gross USD 0.15 paid on Apr 15, 2024 going ex on Mar 28, 2024
Apr 01, 2024
Apr 15, 2024
Mar 28, 2024
Oct 19, 2023
EHC.NB Final Cash Dividend of gross USD 0.15 paid on Jan 16, 2024 going ex on Dec 29, 2023
Jan 02, 2024
Jan 16, 2024
Dec 29, 2023
Jul 20, 2023
EHC.NB Interim Cash Dividend of gross USD 0.15 paid on Oct 16, 2023 going ex on Sep 29, 2023
Oct 02, 2023
Oct 16, 2023
Sep 29, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Encompass Health Corp?
The top five shareholders of Encompass Health Corp are:
The Vanguard Group, Inc. holds 10.22M shares, accounting for 10.15% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 8.48M shares, accounting for 8.43% of the total shares.
Invesco Advisers, Inc. holds 4.48M shares, accounting for 4.45% of the total shares.
T. Rowe Price Associates, Inc. holds 3.77M shares, accounting for 3.74% of the total shares.
State Street Investment Management (US) holds 3.08M shares, accounting for 3.06% of the total shares.
The Vanguard Group, Inc. holds 10.22M shares, accounting for 10.15% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 8.48M shares, accounting for 8.43% of the total shares.
Invesco Advisers, Inc. holds 4.48M shares, accounting for 4.45% of the total shares.
T. Rowe Price Associates, Inc. holds 3.77M shares, accounting for 3.74% of the total shares.
State Street Investment Management (US) holds 3.08M shares, accounting for 3.06% of the total shares.
What are the top three shareholder types of Encompass Health Corp?
The top three shareholder types of Encompass Health Corp are:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Invesco Advisers, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Invesco Advisers, Inc.
How many institutions hold shares of Encompass Health Corp (EHC)?
As of 2025Q4, 1064 institutions hold shares of Encompass Health Corp, with a combined market value of approximately 98.33M, accounting for 97.73% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -1.67%.
What is the biggest source of revenue for Encompass Health Corp?
In FY2025Q2, the Medicare business generated the highest revenue for Encompass Health Corp, amounting to 939.70M and accounting for 64.46% of total revenue.
